Figure 3.
The effect of HBsAg in the study. A, The HBsAg decline of the 2 groups from 0 to 96 weeks and 24 weeks post-EOT. B, The HBsAg value of the 2 groups at 48 and 96 weeks. C, HBsAg decline of the 2 groups with 48 and 96 weeks of treatment. Abbreviation: EOT, end of treatment.

The effect of HBsAg in the study. A, The HBsAg decline of the 2 groups from 0 to 96 weeks and 24 weeks post-EOT. B, The HBsAg value of the 2 groups at 48 and 96 weeks. C, HBsAg decline of the 2 groups with 48 and 96 weeks of treatment. Abbreviation: EOT, end of treatment.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close